Story perspectives

Trump's Executive Order Aims to Cut Drug Prices Amid Tariff Crisis

5/11/2025

36 3

Left

Trump Tackles Drug Prices

Rising tariffs on pharmaceuticals are driving up drug prices in the U.S., hitting uninsured patients the hardest and widening health disparities. In response, President Trump is set to sign an executive order aimed at slashing costs by aligning them with lower international rates, but pharmaceutical companies are pushing back fiercely against this move.

Right

Trump Fights Drug Costs

President Trump is taking a stand against soaring drug prices in the U.S., calling out the pharmaceutical industry for its cost-inflating tactics. He plans to collaborate with Congress to eliminate foreign price controls, which he believes stifle innovation and jeopardize American jobs. His mission is to foster competition and make prescriptions more affordable for patients.

History

Historical Context

Rising tariffs on pharmaceuticals in the U.S. echo historical tensions over drug pricing, reminiscent of the 2003 Medicare prescription drug benefit debate. This legislation aimed to lower costs but faced backlash from pharmaceutical companies, similar to current pushback against President Trump's proposed executive order to align drug prices with international rates. The ongoing struggle highlights persistent conflicts between healthcare affordability and industry interests.

1 of 3

Trump Tackles Drug Prices

Rising tariffs on pharmaceuticals are driving up drug prices in the U.S., hitting uninsured patients the hardest and widening health disparities. In response, President Trump is set to sign an executive order aimed at slashing costs by aligning them with lower international rates, but pharmaceutical companies are pushing back fiercely against this move.

1 / 3